Emcure
-
{
- All
- News
-
Emcure Pharmaceuticals Q2 Results: Profit Jumps 34%, Revenue Up 24%
Emcure Pharmaceuticals' international business grew 34.5% year-on-year in the September quarter, led by strong performances across Europe, Canada, and rest of the world markets.
-
Emcure Pharma Shares Slip As Bain Capital Plans Rs 492.7 Crore Stake Sale
The firm sims to offer nearly 38 lakh shares, or 2% equity, at Rs 1,296.51 apiece, approximately 7% discount to Monday's closing price.
-
Emcure Pharma Block Deal: Bain Capital To Offload Shares Worth Nearly Rs 500 Crore
Bain Capital held a 6.3% stake as of September, currently valued at Rs 1,660 crore.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Emcure Pharma Partners With Novo Nordisk To Launch Weight Loss Injection In India
As part of the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra in India.
-
The 'Shark Tank' Valuation Report: Zomato, Lenskart, Mamaearth, Emcure — Who Gets The Deal?
The valuation debate for these 'shark' companies hinges not only on absolute price to earnings or price to sales metrics, but on growth ceiling and market scope as well.
-
Emcure Pharma Q1 Results: Net Profit Up 41% At Rs 215 Crore
Revenue from operations in the quarter under review stood at Rs 2,101 crore as against Rs 1,815 crore in the year-ago period.
-
Buy, Sell Or Hold: BEL, SBI, Varun Beverages, Suzlon Energy, SRF — Ask Profit
Market analysts also shared buy, sell and hold recommendations for stocks like Emcure Pharmaceuticals and Force Motors.
-
Stocks To Watch Today: TCS, Tata Elxsi, Amber Enterprises, JSW Energy, Oil India, Ambuja Cements
Asian Paints and UPL are also some of the stocks to watch on Thursday.
-
Emcure Pharmaceuticals Bulk Deal: BC Investments Offloads Stake For Rs 563 Crore
The public shareholder sold the 2.37% stake for Rs 1,250.44 apiece.
-
Emcure Pharma Block Deal: Public Shareholder BC Investments To Sell 2.4% Stake
Kotak Securities will be the book runners for the deal.
-
Emcure Pharma To Acquire 20% Stake In Zuventus Healthcare For Rs 724.9 Crore
Emcure Pharma to acquire remaining 20.42 pc stake in Zuventus Healthcare for Rs 724.9 cr
-
Emcure Pharma Arm Ties Up With Italy’s WiQo To Sell Skin Tightening Product In India; Shares Rise
The partnership allows the Emcure subsidiary to sell WiQo’s "topical painless booster used for skin tightening".
-
Emcure Pharma Gets Form 483 With Two Observations For API Plant From USFDA
Emcure Pharma gets Form 483 with two observations for API plant from USFDA
-
Emcure Pharmaceuticals Q2 Results: Profit Jumps 34%, Revenue Up 24%
Emcure Pharmaceuticals' international business grew 34.5% year-on-year in the September quarter, led by strong performances across Europe, Canada, and rest of the world markets.
-
Emcure Pharma Shares Slip As Bain Capital Plans Rs 492.7 Crore Stake Sale
The firm sims to offer nearly 38 lakh shares, or 2% equity, at Rs 1,296.51 apiece, approximately 7% discount to Monday's closing price.
-
Emcure Pharma Block Deal: Bain Capital To Offload Shares Worth Nearly Rs 500 Crore
Bain Capital held a 6.3% stake as of September, currently valued at Rs 1,660 crore.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Emcure Pharma Partners With Novo Nordisk To Launch Weight Loss Injection In India
As part of the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra in India.
-
The 'Shark Tank' Valuation Report: Zomato, Lenskart, Mamaearth, Emcure — Who Gets The Deal?
The valuation debate for these 'shark' companies hinges not only on absolute price to earnings or price to sales metrics, but on growth ceiling and market scope as well.
-
Emcure Pharma Q1 Results: Net Profit Up 41% At Rs 215 Crore
Revenue from operations in the quarter under review stood at Rs 2,101 crore as against Rs 1,815 crore in the year-ago period.
-
Buy, Sell Or Hold: BEL, SBI, Varun Beverages, Suzlon Energy, SRF — Ask Profit
Market analysts also shared buy, sell and hold recommendations for stocks like Emcure Pharmaceuticals and Force Motors.
-
Stocks To Watch Today: TCS, Tata Elxsi, Amber Enterprises, JSW Energy, Oil India, Ambuja Cements
Asian Paints and UPL are also some of the stocks to watch on Thursday.
-
Emcure Pharmaceuticals Bulk Deal: BC Investments Offloads Stake For Rs 563 Crore
The public shareholder sold the 2.37% stake for Rs 1,250.44 apiece.
-
Emcure Pharma Block Deal: Public Shareholder BC Investments To Sell 2.4% Stake
Kotak Securities will be the book runners for the deal.
-
Emcure Pharma To Acquire 20% Stake In Zuventus Healthcare For Rs 724.9 Crore
Emcure Pharma to acquire remaining 20.42 pc stake in Zuventus Healthcare for Rs 724.9 cr
-
Emcure Pharma Arm Ties Up With Italy’s WiQo To Sell Skin Tightening Product In India; Shares Rise
The partnership allows the Emcure subsidiary to sell WiQo’s "topical painless booster used for skin tightening".
-
Emcure Pharma Gets Form 483 With Two Observations For API Plant From USFDA
Emcure Pharma gets Form 483 with two observations for API plant from USFDA
